SUMMARY The selective removal from 2-amino-2-methyI-I-propanol solutions of impurities that inhibit alkaline phosphatase activity by means of Amberlite chromatography is described. The effects of buffer concentration, column dimensions, adsorbent type, and zinc sulphate addition were investigated. The method was found to improve greatly the quality of commercial 2-amino-2-methyl-l-propanol solutions and to have several advantages over alternative purification methods.
Diethanolamine (DEA) and 2-amino-2-methyl-lpropanol (2A2M I P) are the most widely used buffer substances in the assay of serum alkaline phosphatase activity. Unfortunately, commercially available preparations of both compounds have been shown Materials and methods to contain varying amounts of alkaline phosphatase inhibiting impurities.vP Monoethanolamine was From 17 different lots of 2A2M IP obtained from identified in several DEA preparations, and its eight suppliers, those preparations showing varying inhibitory effect on alkaline phosphatase was inhibitory effects on alkaline phosphatase were established.f selected and used in the experiments. 4-NitrophenylAlkaline phosphatase inhibition by impure phosphate was purchased from BDH, Poole, UK, 2A2M I P has been observed in those methods in and all other reagents from Merck, Darmstadt, which the kinetic measurement was initiated by the West Germany. In all experiments, doubly distilled addition of substrate (4-nitrophenyl-phosphate) to a water was used in which no zinc could be detected preincubated mixture of serum sample and buffer by means of atomic absorption spectrometry solution." It was found that the inhibitory effect (detection limit 0·08 flomol/!). Monitrol liE control increased with increasing preincubation time. serum was obtained from Merz and Dade, Inhibition could be prevented by adding zinc (II) Duedingen, Switzerland. In addition to its good to the reaction mixture, but the amount of zinc stability, this control serum behaved similarly to needed depended critically on the degree of irn-human serum as previously described," and therefore purity of the 2A2M 1P used." this serum was selected as a reliable model serum Chloroform extraction of 2A2M I P buffer solu-for the various experiments. The control serum was tions was reported previously to be very effective reconstituted and left at room temperature for in removing inhibitors from 2A2M IP solutions." 20 hours before analysis. The alkaline phosphatase Nevertheless, this method showed several minor activity determinations were carried out with a disadvantages. Apart from being laborious and timeCobas-Bio centrifugal analyser (Hoffman-LaRoche, consuming it gave rise to some loss of 2A2M I P Basle, Switzerland). The final concentrations of the from the buffer solutions. Further, some chloroform ingredients during the reaction were: 4-nitrophenylwas left in the purified buffers, which might have an phosphate, 16 mrnol/l ; magnesium sulphate, 0·1 adverse effect on alkaline phosphatase determina-rnrnol/l: 2A2MIP, 0·51, 0·64, and 0·85 molfl tion. We describe a method for the purification of (pH 10·6) and zinc sulphate, 0-0·0\ mrnol/L The 2A2MI P buffer solutions based on chromatography reaction parameters entered into the Cobas-Bio on a neutral resin. Because it does not have the programmer are listed in Table I .
182 By gas chromatography the 2A2M IP concentration of the column eluates was checked at regular intervals to assess which parts of the eluates had to be discarded because of insufficient 2A2M IP content. The purified 2A2MIP solution collected in one or several fractions (see below) was adjusted to pH 10·6 with concentrated hydrochloric acid using a pH meter equipped with a Trizma (Sigma, St. Louis, MO, USA) electrode, and used in alkaline phosphatase determinations.
Reaction parameters used in the Cobas-Bio
Experiments and results
"Kinetic with starting reagent
The 2A2M I P concentrations of untreated and treated buffer solutions were determined by gas chromatography as described elsewhere." Two different neutral resins, viz, Servachrorn (Amberlite) XAD-2 and Servachrom XAD-4, were purchased from Serva, Heidelberg, West Germany. XAD-2 was obtained in two different grades having particle sizes of 300-1000 fl. and 200-250 fl., respectively, while XAD-4 was available as the 300-1000 fl. grade only.
The chromatography columns used for the purification of 2A2M IP solutions were prepared as follows. Neutral resin was washed five times with five volumes of water to remove fines, and packed subsequently into glass columns of 27 mrn internal diameter equipped with a 500 ml solvent reservoir. Bed heights varied from 80 to 480 mrn and cotton wool plugs were used to support and cover the resin. To the bottom end of the columns a flow restriction made from approximately 10 mm of 0·25 mm id Technicon (Tarrytown, New York, USA) Tygon tubing was attached to obtain a flow rate of approximately 1·2 rnl/min; 200-500 ml of 0·63-1 ·04 mol/I 2A2Ml P solutions in water were applied to these columns and the eluate was collected in several fractions as mentioned below. For easy reference the procedure for 27 x 240 mm XAD-4 columns, which proved to be both practical and efficient, is described in detail.
Five hundred rnillilitres of 2A2M IP solution of the desired concentration is put into the reservoir on top of the column. The first 145 ml of eluate is collected and discarded. Then, the purified 2A2MIP is collected until the reservoir is empty. One hundred millilitres of water is put into the reservoir and the collection of purified 2A2Ml P is continued until all water has drained into the column bed. The column is then regenerated by passing 200 ml of ethanol followed by 400 ml of water through the column. After this treatment the column can be used again.
Two hundred millilitre portions of 0·63 mol/I solutions prepared from three 2A2M I P preparations of varying quality were purified by chromatography on Amberlite XAD-2 (particle size 300-1000 fl.) columns. Gas chromatography showed that, if a resin bed of dimensions 80 x 27 mm was used, the first 60 ml of eluate had to be discarded due to column hold-up and chromatographic dilution effects. Subsequently, a 180 ml fraction of purified 2A2MIP solution was collected, the composition of which was identical with that of the original solution. Zinc concentrations in both untreated and purified 2A2M 1P solutions were determined by atomic absorption spectrometry and did not differ significantly (mean concentration approximately 0·3 umoljl).
The alkaline phosphatase activities of Monitrol lIE control serum determined with the use of both the purified and untreated buffers are presented in Table 2 . All activities are expressed as percentage of the activity found using a 0·63 mol/l solution of a 2A2MlP purified by chloroform extraction." The activities were determined with and without addition of 0·01 mrnol/l zinc (II) sulphate. Then buffer solutions of varying concentrations were prepared from the 2A2M1 P lot which showed the largest inhibitory effect on alkaline phosphatase of all lots tested. Five hundred millilitre portions of these solutions were chromatographed on Amberlite XAD-4 (particle size 300-1000 fl.) columns, and the eluate was collected in five fractions of approximately 95 ml. Also, 500 ml portions of a 1·04 mol/I solution prepared from the same 2A2M IP lot were chromatographed on columns of varying resin type and bed height. In each instance the eluate was collected as one fraction of approximately 480 ml, Then 51 of a 0·63 mol/l solution of the same 2A2M I P lot was chromatographed on a 480 x 27 rnm column packed with Amberlite XAD-4 (300-1000 fl.) and 4·5 I of eluate was collected in nine fractions of 500 ml. The results of the alkaline phosphatase determinations carried out with these buffers are summarised in Table 3 . To determine the influence of buffer concentration on alkaline phosphatase activity, portions taken from the more concentrated solutions (0·78 and 1·04 mol/!) were diluted to 0·63 mol/I and tested in the alkaline phosphatase assay (see Table 3 ).
Finally, 47 human serum samples with widely varying alkaline phosphatase activities were analysed using both buffer purified on a 240 x 27 mm XAD-4 (300-1000 fl.) column and untreated buffer. In addition, these samples were tested using both the reagent concentrations recommended by the Nederlandse Vereniging voor Klinische Chemie (final concentrations: 2A2MIP 0·9 mol/l, magnesium sulphate 1·0 mmol/I) and those mentioned before
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(2A2MIP 0·51 moll I, magnesium sulphate 0·1 mmol/!). The results are presented in the Figure. 
Discussion
Amberlite XAD-2 neutral resin has been extensively used to isolate organic substances covering a wide polarity range from aqueous solutions. This material strongly resembles reversed-phase chromatography materials? and substances adsorbed onto it can usually be eluted by solvents of lower polarity than water. From the literature" as well as from specifications provided by the manufacturer," it is known that commercial 2A2M IP is contaminated by higher alkyldiamines, and it has been suggested previously3, 5 that these diamines effectively chelate Zn (II) ions, which are essential to the catalytic action of alkaline phosphatase. The purifying action of Amberlite XAD materials on 2A2M IP solutions is easily explained by selective adsorption of the relatively apolar higher alkyldiamines from the buffer solutions.
The 2A2M IP concentration of the solutions was not affected by Amberlite chromatography, as was shown by gas chromatography. This constitutes a distinct advantage of Amberlite chromatography compared with selective solvent extraction."
At first glance, Table 3 might suggest that the purification efficiency decreased with increasing 2A2M IP concentration of the treated solutions. However, when the more concentrated solutions were diluted to o·63 rnol/l after purification, the activities found were even slightly higher than those 
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Activities measured either in total eluate or in individual fractions. In the latter case both the highest and the lowest activity found arc given; in parentheses the number of fractions. In all cases activity decreased with increasing fraction number. Activitics in purified buffers as such and after dilution to 0·63 mol/llfinal concentration 0·5111101/1). IIWith or without addition of 10 umol of zinc sulphate ncr litre to the reaction mixture. 
respectively. The excellent correlations found strongly indicate that the effect of purification is largely independent of variations in serum composition. In agreement with earlier observations, dilution of untreated 0·9 mcl/l 2A2Ml P to 0·51 mol/I resulted in an increase in activity of 32~Io as derived from the third regression equation. In contrast, the difference found using purified 0·9 mol/l and 0·51 mol/l buffers was only 4 % as calculated by dividing the regression coefficients of the second and first equations, respectively. In conclusion, it can be stated that the method described above largely eliminates the problem of the impurities present in 2A2MI P that inhibit alkaline phosphatase. In addition, the method is inexpensive and requires attention only when the column is loaded with either raw solution or regenerating solvents. Repetitive use of the columns up to ten times did not affect their purifying action. and indefinite use is feasible. Further, the method can be automated easily and may be used for on-line purification of ready-to-use buffers in automated analysis systems.
Clearly, the quality of the purified 2A2Ml Psolution decreased slightly with increasing elution volume. As might be expected, this problem was largely eliminated by increasing column bed height. When a 480x 27 mm column was used 41 of 0·63 molj! 2A2M IP of essentially constant quality was eluted.
The addition of 0·01 rnrnol/l zinc sulphate increased the enzyme activity slightly. A similar observation was made for 2A2M IP buffers purified by selective solvent extraction." This might be an additional indication that small amounts of impurities that inhibit alkaline phosphatase are still present in the treated buffers. Alternatively, it might indicate that the amount of zinc in the reaction mixture contributed by the serum sample alone was suboptimal.
The Figure shows the alkaline phosphatase activities of 47 human serum samples determined, using purified 0·9 rnol/l 2A2MIP and both purified and untreated 0·51 mol/l buffer, as functions of the activities found using untreated 0·9 mol/l buffer. The regression parameters calculated for these functions were found using the purified 0·63 rnol/! solution. Possibly, residual impurities in the purified solutions are responsible for this effect. Considering the data presented here, it may be preferable to use final 2A2 M 1P concentrations of 0·5--0·6 mol/I rather than higher concentrations in order to minimise the effects of poor buffer quality. Concentrations lower than 0·5 mol/l were not tested, because there is evidence from the literature that alkaline phosphatase activity decreases with decreasing 2A2M IP concentration below 0·5mo1/1.
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From Table 3 it appears that there are only small differences between the various types of Amberlite as far as purification efficiency is concerned. As the 300-1000 fJ. types are relatively inexpensive, they are the materials of choice. 
